Health plan medical director: considerations for prevention and management of RSV disease.
At Humana, our intent is to provide RSV immunoprophylaxis to all our members who need it quickly and efficiently. Humana's CareHub is a collaborative guidance model that fully engages our members and their health care providers, and allows us to leverage technology to develop a comprehensive clinical profile for each member and to share information. This clinical profile provides many ways in which we can identify those children who are at high risk of severe RSV infection, allowing us to implement RSV treatment and management quickly and effectively before the RSV season begins.
Tzeel
Albert
A
Humana Wisconsin, Waukesha, Wis., USA.
D000555:Ambulatory Care Information Systems; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use; D018890:Chemoprevention; D019468:Disease Management; D006801:Humans; D008329:Managed Care Programs; D017146:Models, Organizational; D019982:Organizational Case Studies; D000069455:Palivizumab; D012042:Registries; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*; D012307:Risk Factors; D012621:Seasons; D014481:United States / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab